Key Financial Data Of Group

Mochida Pharmaceutical Co.,Ltd. - Filing #7245397

Concept As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
Key financial data of group
Business results of group
Net sales
105,159,000,000 JPY
95,410,000,000 JPY
94,243,000,000 JPY
102,885,000,000 JPY
95,486,000,000 JPY
103,261,000,000 JPY
102,439,000,000 JPY
110,179,000,000 JPY
95,334,000,000 JPY
102,995,000,000 JPY
Ordinary profit (loss)
8,067,000,000 JPY
7,571,000,000 JPY
5,355,000,000 JPY
6,037,000,000 JPY
8,971,000,000 JPY
9,085,000,000 JPY
13,539,000,000 JPY
14,799,000,000 JPY
11,626,000,000 JPY
12,260,000,000 JPY
Profit (loss) attributable to owners of parent
5,685,000,000 JPY
4,547,000,000 JPY
6,649,000,000 JPY
10,569,000,000 JPY
8,587,000,000 JPY
Comprehensive income
5,567,000,000 JPY
7,567,000,000 JPY
5,001,000,000 JPY
7,619,000,000 JPY
11,412,000,000 JPY
Net assets
130,694,000,000 JPY
128,457,000,000 JPY
127,967,000,000 JPY
126,336,000,000 JPY
125,109,000,000 JPY
126,775,000,000 JPY
128,646,000,000 JPY
126,385,000,000 JPY
126,974,000,000 JPY
124,894,000,000 JPY
Total assets
160,121,000,000 JPY
153,128,000,000 JPY
158,800,000,000 JPY
152,166,000,000 JPY
152,386,000,000 JPY
158,831,000,000 JPY
163,139,000,000 JPY
156,837,000,000 JPY
161,791,000,000 JPY
155,605,000,000 JPY
Net assets per share
3,686.69
3,623.58
3,609.64
3,563.63
3,424.59
3,470.18
3,424.21
3,364.03
3,317.92
3,263.57
Basic earnings (loss) per share
160.36
151.87
130.27
126.80
195.10
178.93
274.03
277.39
232.56
222.29
Diluted earnings per share
Equity-to-asset ratio
0.816 xbrli:pure
0.839 xbrli:pure
0.806 xbrli:pure
0.830 xbrli:pure
0.821 xbrli:pure
0.798 xbrli:pure
0.789 xbrli:pure
0.806 xbrli:pure
0.785 xbrli:pure
0.803 xbrli:pure
Rate of return on equity
0.044 xbrli:pure
0.042 xbrli:pure
0.037 xbrli:pure
0.036 xbrli:pure
0.058 xbrli:pure
0.052 xbrli:pure
0.083 xbrli:pure
0.083 xbrli:pure
0.074 xbrli:pure
0.069 xbrli:pure
Price-earnings ratio
19.8 xbrli:pure
20.9 xbrli:pure
24.7 xbrli:pure
25.4 xbrli:pure
17.1 xbrli:pure
18.7 xbrli:pure
13.6 xbrli:pure
13.5 xbrli:pure
18.4 xbrli:pure
19.3 xbrli:pure
Net cash provided by (used in) operating activities
9,354,000,000 JPY
-7,480,000,000 JPY
7,297,000,000 JPY
7,459,000,000 JPY
9,198,000,000 JPY
Net cash provided by (used in) investing activities
17,355,000,000 JPY
74,000,000 JPY
-2,949,000,000 JPY
-2,007,000,000 JPY
-880,000,000 JPY
Net cash provided by (used in) financing activities
-2,865,000,000 JPY
-6,393,000,000 JPY
-6,884,000,000 JPY
-5,956,000,000 JPY
-5,112,000,000 JPY
Cash and cash equivalents
48,151,000,000 JPY
24,290,000,000 JPY
38,010,000,000 JPY
40,515,000,000 JPY
40,987,000,000 JPY
Number of employees
122 xbrli:pure
1,508 xbrli:pure
1,237 xbrli:pure
122 xbrli:pure
1,522 xbrli:pure
1,247 xbrli:pure
1,252 xbrli:pure
1,529 xbrli:pure
1,544 xbrli:pure
1,280 xbrli:pure
1,558 xbrli:pure
1,298 xbrli:pure
Average number of temporary employees
16 xbrli:pure
491 xbrli:pure
192 xbrli:pure
24 xbrli:pure
495 xbrli:pure
194 xbrli:pure
202 xbrli:pure
515 xbrli:pure
503 xbrli:pure
195 xbrli:pure
504 xbrli:pure
189 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.